Detalles de la búsqueda
1.
Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting.
Wound Repair Regen
; 23(5): 737-44, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26100572
2.
Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers.
Wound Repair Regen
; 22(3): 334-40, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24628712
3.
Real-World Comparative Effectiveness Assessment Study of a Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial and a Cryopreserved Cadaveric Skin Allograft for Use in Diabetic Foot Ulcers - A Non-inferiority Analysis.
Eplasty
; 24: e16, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685995
4.
Real-world data analysis of bilayered living cellular construct and fetal bovine collagen dressing treatment for pressure injuries: a comparative effectiveness study.
J Comp Eff Res
; 13(4): e230109, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348818
5.
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
J Card Fail
; 18(8): 600-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22858074
6.
Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds.
J Comp Eff Res
; 9(10): 691-703, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476449
7.
A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers.
J Comp Eff Res
; 9(1): 23-34, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31691579
8.
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
J Card Fail
; 15(3): 191-8, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19327620
9.
Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
J Comp Eff Res
; 8(14): 1229-1238, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407588
10.
Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
Wound Manag Prev
; 65(9): 26-34, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702990
11.
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Circulation
; 115(13): 1747-53, 2007 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-17372175
12.
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.
J Card Fail
; 14(9): 718-23, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18995175
13.
Comparative effectiveness of a bilayered living cellular construct and an acellular fetal bovine collagen dressing in the treatment of venous leg ulcers.
J Comp Eff Res
; 7(8): 797-805, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29809059
14.
Comparative Effectiveness of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real-World Setting.
Adv Wound Care (New Rochelle)
; 7(3): 69-76, 2018 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29644144
15.
Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
Clin Pharmacokinet
; 46(10): 885-95, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17854237
16.
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
Am J Cardiol
; 100(4): 684-9, 2007 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17697829
17.
Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
J Card Fail
; 13(5): 331-9, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17602978
18.
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Am J Cardiovasc Drugs
; 7(5): 373-80, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18041162
19.
The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
Wounds
; 29(5): 125-132, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28570252
20.
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Circulation
; 112(24): 3745-53, 2005 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-16344404